Literature DB >> 23152505

Increasing expression of microRNA 181 inhibits porcine reproductive and respiratory syndrome virus replication and has implications for controlling virus infection.

Xue-kun Guo1, Qiong Zhang, Li Gao, Ning Li, Xin-xin Chen, Wen-hai Feng.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most important viral pathogens in the swine industry. Emerging evidence indicates that the host microRNAs (miRNAs) are involved in host-pathogen interactions. However, whether host miRNAs can target PRRSV and be used to inhibit PRRSV infection has not been reported. Recently, microRNA 181 (miR-181) has been identified as a positive regulator of immune response, and here we report that miR-181 can directly impair PRRSV infection. Our results showed that delivered miR-181 mimics can strongly inhibit PRRSV replication in vitro through specifically binding to a highly (over 96%) conserved region in the downstream of open reading frame 4 (ORF4) of the viral genomic RNA. The inhibition of PRRSV replication was specific and dose dependent. In PRRSV-infected Marc-145 cells, the viral mRNAs could compete with miR-181-targeted sequence in luciferase vector to interact with miR-181 and result in less inhibition of luciferase activity, further demonstrating the specific interactions between miR-181 and PRRSV RNAs. As expected, miR-181 and other potential PRRSV-targeting miRNAs (such as miR-206) are expressed much more abundantly in minimally permissive cells or tissues than in highly permissive cells or tissues. Importantly, highly pathogenic PRRSV (HP-PRRSV) strain-infected pigs treated with miR-181 mimics showed substantially decreased viral loads in blood and relief from PRRSV-induced fever compared to negative-control (NC)-treated controls. These results indicate the important role of host miRNAs in modulating PRRSV infection and viral pathogenesis and also support the idea that host miRNAs could be useful for RNA interference (RNAi)-mediated antiviral therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152505      PMCID: PMC3554091          DOI: 10.1128/JVI.02386-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  Antiviral silencing in animals.

Authors:  Hong-Wei Li; Shou-Wei Ding
Journal:  FEBS Lett       Date:  2005-08-31       Impact factor: 4.124

Review 2.  Nidovirus transcription: how to make sense...?

Authors:  Alexander O Pasternak; Willy J M Spaan; Eric J Snijder
Journal:  J Gen Virol       Date:  2006-06       Impact factor: 3.891

3.  Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

Authors:  Frank Cichocki; Martin Felices; Valarie McCullar; Steven R Presnell; Ahmad Al-Attar; Charles T Lutz; Jeffrey S Miller
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

4.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

Review 5.  Molecular characterization of positive-strand RNA viruses: pestiviruses and the porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  H J Thiel; G Meyers; R Stark; N Tautz; T Rümenapf; G Unger; K K Conzelmann
Journal:  Arch Virol Suppl       Date:  1993

6.  Interferon modulation of cellular microRNAs as an antiviral mechanism.

Authors:  Irene M Pedersen; Guofeng Cheng; Stefan Wieland; Stefano Volinia; Carlo M Croce; Francis V Chisari; Michael David
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

Review 7.  Current prospects for RNA interference-based therapies.

Authors:  Beverly L Davidson; Paul B McCray
Journal:  Nat Rev Genet       Date:  2011-05       Impact factor: 53.242

8.  Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

Authors:  Thomas W Geisbert; Amy C H Lee; Marjorie Robbins; Joan B Geisbert; Anna N Honko; Vandana Sood; Joshua C Johnson; Susan de Jong; Iran Tavakoli; Adam Judge; Lisa E Hensley; Ian Maclachlan
Journal:  Lancet       Date:  2010-05-29       Impact factor: 79.321

9.  Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.

Authors:  Bao-jian Li; Qingquan Tang; Du Cheng; Chuan Qin; Frank Y Xie; Qiang Wei; Jun Xu; Yijia Liu; Bo-jian Zheng; Martin C Woodle; Nanshan Zhong; Patrick Y Lu
Journal:  Nat Med       Date:  2005-08-21       Impact factor: 53.440

10.  Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  X Duan; H J Nauwynck; M B Pensaert
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

View more
  68 in total

1.  MicroRNA transcriptome analysis of poly I:C-stimulated and PRRSV-infected porcine alveolar macrophages.

Authors:  Junjing Wu; Ziyun Ji; Mu Qiao; Xianwen Peng; Huayu Wu; Zhongxu Song; Haizhong Zhao; Guisheng Liu; Fenge Li; Shuqi Mei
Journal:  J Appl Genet       Date:  2019-06-22       Impact factor: 3.240

2.  MicroRNA 181 suppresses porcine reproductive and respiratory syndrome virus (PRRSV) infection by targeting PRRSV receptor CD163.

Authors:  Li Gao; Xue-kun Guo; Lianghai Wang; Qiong Zhang; Ning Li; Xin-xin Chen; Yongqiang Wang; Wen-hai Feng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

3.  Integrated miRNA and mRNA transcriptomes of porcine alveolar macrophages (PAM cells) identifies strain-specific miRNA molecular signatures associated with H-PRRSV and N-PRRSV infection.

Authors:  Peiqing Cong; Shuqi Xiao; Yaosheng Chen; Liangliang Wang; Jintao Gao; Ming Li; Zuyong He; Yunxue Guo; Guangyin Zhao; Xiaoyu Zhang; Luxi Chen; Delin Mo; Xiaohong Liu
Journal:  Mol Biol Rep       Date:  2014-06-25       Impact factor: 2.316

4.  Epigenetic Upregulation of Chicken MicroRNA-16-5p Expression in DF-1 Cells following Infection with Infectious Bursal Disease Virus (IBDV) Enhances IBDV-Induced Apoptosis and Viral Replication.

Authors:  Xueyan Duan; Mingliang Zhao; Yongqiang Wang; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

5.  Highly pathogenic porcine reproductive and respiratory syndrome virus induces prostaglandin E2 production through cyclooxygenase 1, which is dependent on the ERK1/2-p-C/EBP-β pathway.

Authors:  Yanmin Bi; Xue-kun Guo; Haiyan Zhao; Li Gao; Lianghai Wang; Jun Tang; Wen-hai Feng
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 6.  The use of microRNAs to modulate redox and immune response to stroke.

Authors:  Yi-Bing Ouyang; Creed M Stary; Robin E White; Rona G Giffard
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

7.  High-Throughput Fluorescence-Based Screen Identifies the Neuronal MicroRNA miR-124 as a Positive Regulator of Alphavirus Infection.

Authors:  Paula López; Erika Girardi; Bryan C Mounce; Amélie Weiss; Béatrice Chane-Woon-Ming; Mélanie Messmer; Pasi Kaukinen; Arnaud Kopp; Diane Bortolamiol-Becet; Ali Fendri; Marco Vignuzzi; Laurent Brino; Sébastien Pfeffer
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

8.  TLR-4/microRNA-125a/NF-κB signaling modulates the immune response to Mycobacterium tuberculosis infection.

Authors:  Wenyi Niu; Bing Sun; Mingying Li; Junwei Cui; Jian Huang; Ligong Zhang
Journal:  Cell Cycle       Date:  2018-09-06       Impact factor: 4.534

Review 9.  MicroRNAs: history, biogenesis, and their evolving role in animal development and disease.

Authors:  M Bhaskaran; M Mohan
Journal:  Vet Pathol       Date:  2013-09-17       Impact factor: 2.221

10.  MiR-506 inhibits PRRSV replication in MARC-145 cells via CD151.

Authors:  Junjing Wu; Xianwen Peng; Ao Zhou; Mu Qiao; Huayu Wu; Hongwei Xiao; Guisheng Liu; Xinmin Zheng; Shujun Zhang; Shuqi Mei
Journal:  Mol Cell Biochem       Date:  2014-05-31       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.